These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 18792903)
1. On the art of compiling and using 'drug-like' chemical fragment spaces. Degen J; Wegscheid-Gerlach C; Zaliani A; Rarey M ChemMedChem; 2008 Oct; 3(10):1503-7. PubMed ID: 18792903 [No Abstract] [Full Text] [Related]
2. De novo drug design. Hartenfeller M; Schneider G Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974 [TBL] [Abstract][Full Text] [Related]
3. Design strategies for building drug-like chemical libraries. Mitchell T; Showell GA Curr Opin Drug Discov Devel; 2001 May; 4(3):314-8. PubMed ID: 11560064 [TBL] [Abstract][Full Text] [Related]
4. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. Blum LC; Reymond JL J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099 [TBL] [Abstract][Full Text] [Related]
5. A data mining method to facilitate SAR transfer. Wassermann AM; Bajorath J J Chem Inf Model; 2011 Aug; 51(8):1857-66. PubMed ID: 21774471 [TBL] [Abstract][Full Text] [Related]
6. Kinase patent space visualization using chemical replacements. Southall NT; Ajay J Med Chem; 2006 Mar; 49(6):2103-9. PubMed ID: 16539399 [TBL] [Abstract][Full Text] [Related]
7. Selective optimization of side activities: another way for drug discovery. Wermuth CG J Med Chem; 2004 Mar; 47(6):1303-14. PubMed ID: 14998318 [No Abstract] [Full Text] [Related]
8. Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers. Monge A; Arrault A; Marot C; Morin-Allory L Mol Divers; 2006 Aug; 10(3):389-403. PubMed ID: 17031540 [TBL] [Abstract][Full Text] [Related]
9. Competitive Workflow: novel software architecture for automating drug design. Cartmell J; Krstajic D; Leahy DE Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862 [TBL] [Abstract][Full Text] [Related]
10. Virtual Discovery Europe--Select Biosciences Conference. Computer-aided drug design and screening. Kubinyi H IDrugs; 2007 Dec; 10(12):869-73. PubMed ID: 18041683 [No Abstract] [Full Text] [Related]
12. Drug discovery: the leading edge. Chapman T Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608 [No Abstract] [Full Text] [Related]
13. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2006. Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Salvino JM; Zhang W J Comb Chem; 2007; 9(6):855-902. PubMed ID: 17877417 [No Abstract] [Full Text] [Related]
14. What do medicinal chemists actually make? A 50-year retrospective. Walters WP; Green J; Weiss JR; Murcko MA J Med Chem; 2011 Oct; 54(19):6405-16. PubMed ID: 21755928 [No Abstract] [Full Text] [Related]
15. Extraction and analysis of chemical modification patterns in drug development. Shigemizu D; Araki M; Okuda S; Goto S; Kanehisa M J Chem Inf Model; 2009 Apr; 49(4):1122-9. PubMed ID: 19391632 [TBL] [Abstract][Full Text] [Related]
17. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. Dobson PD; Patel Y; Kell DB Drug Discov Today; 2009 Jan; 14(1-2):31-40. PubMed ID: 19049901 [TBL] [Abstract][Full Text] [Related]